Castle Biosciences Inc — Liquidità (NASDAQ:CSTL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 9.87 M-18.98 M-41.66 M-5.63 M64.87 M64.35 M 64.35 M Flussi di cassa derivanti dalle attività di investimento -4.75 M-66.66 M-166.54 M-16.18 M-50.14 M-60.37 M -60.37 M Liquidità derivante dalle attività di finanziamento 305.89 M5.42 M1.51 M-2.3 M6.14 M-6.96 M -6.96 M Liquidità libera 5.11 M-22.47 M-47.29 M-19.25 M36.54 M28.33 M 28.33 M

Notizie

Il CEO di Castle Biosciences Maetzold vende azioni per 106.598$

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL)

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents

United Therapeutics Stock Surges 32% in 6 Months: Here's Why

Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Stokes Frank vende titoli Castle Biosciences (CSTL) per 192.000$

Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k

LLY Wins CHMP Nod for Olumiant's Expanded Use in Alopecia Areata